AnginaX AI, India's first intelligent cardiology assistant, is rapidly gaining recognition within the medical community. Following a successful real-world pilot, AnginaX is now preparing for its nationwide deployment on World Health Day – April 7, 2025—marking a transformational shift in cardiovascular care.
Pilot Study Confirms the Need for Early Intervention
Under the leadership of Dr. V. N. Shah (Senior Endocrinologist) and Dr. Sunil Thanvi (Professor & Head of Cardiology) in one of Ahmedabad’s renowned hospitals, the pilot program uncovered a startling reality—68% of 1,030 patients had significant cardiovascular risks they were unaware of.
By identifying core metabolic dysfunctions before symptoms appeared, doctors successfully intervened without last-minute emergency care or invasive procedures. The results underscore the urgent need for structured, systematic early intervention, ensuring no potential risk is overlooked.
Hospitals & Clinics Are Rapidly Integrating AnginaX AI
Following the pilot’s success, hospitals and clinics across Gujarat, Maharashtra, and Karnataka have expressed strong interest in integrating AnginaX AI into their clinical workflows. The overwhelming response signals a paradigm shift toward proactive intervention models, equipping physicians with structured insights that enhance decision-making and optimize patient care.
Why Hospitals & Clinics Are Adopting AnginaX AI
Intervening Before Symptoms Appear –
Leveraging the Latest Scientific Research –
Reducing Late-Stage Interventions – Preventing cardiovascular emergencies before they happen.
Seamless Integration Across Institutions
Empowering Doctors to See More Patients Without Compromising Quality – AnginaX reduces administrative workload by 80%, enabling doctors to intervene three times more efficiently than traditional methods.
Experts Weigh In on the Future of Preventive
Dr. Neeraj Desai (Cardiologist and Chief Medical Advisor)
AnginaX AI equips healthcare professionals with real-time insights, enabling them to prioritize high-risk patients and intervene at the right moment. This is how we prevent cardiovascular events before they happen."
Mahati Munikoti (Senior Biologist & Data Scientist)
"Scientific information is vast and narrowing it down to the right biomarkers for specific populations was key to our successful pilot. Every individual metabolizes differently, and the treatment should never be genialized."
A Conversation with Naman Gosalia, Founder of AnginaX AI
What is AnginaX, and Why Are Doctors Embracing It?
Doctors are already embracing AnginaX—because this is the innovation they’ve been waiting for. For years, they’ve had to work within outdated systems that slow them down. AnginaX changes that.
Built on deep scientific research and an advanced in-house AI model, AnginaX delivers instant, high-precision risk assessments, providing doctors with everything they need in less than a minute. The entire intervention is completed in under five minutes—without adding to their workload.
Doctors are life savers. They need intelligent tools that empower them so they can focus on what truly matters—saving lives.
This isn’t a change or a transition—it’s a long-overdue breakthrough, already in clinical trials and making an impact.
What Makes AnginaX Different?
"The scientific research behind AnginaX is fundamentally distinct—we don’t just provide insights; we translate them into structured intelligence. This system is an advanced medical assistant—headless, yet seamlessly aligned with a doctor’s expertise.
We are not just ‘bridging the gap’ between science and medicine; we are merging them into one unified, intelligent system."
AnginaX was built in India. what makes it the right place for this innovation?
"Why not India? India has the expertise, the research capabilities, and the urgency to innovate at scale. This is India’s innovation for the world.
The same system built here will serve hospitals globally, setting a new standard in cardiovascular care."
What Do You Have to Say About the Pilot’s Success?
"We knew this. Over 70% of global healthcare costs are spent on chronic diseases. The current medical model is designed for acute care, not for treating underlying conditions.
The pilot proved what we expected—most patients were moderately to severely at risk, and they had no idea. There’s no point in playing a gamble with our health anymore. Angina, shortness of breath, dizziness, and pain should no longer be the first warning signs.
Elevated biomarkers should be treated long before symptoms appear.
We were confident in the pilot results. This was not a question of success—it was a validation of what we knew all along. We’ve built *something groundbreaking, something that will revolutionize how the world fights chronic diseases."
When Will AnginaX Be Available to the Public?
"Starting April 7, 2025, patients in Tier 1 cities can visit their family doctors and begin preventive measures. We are actively working with state governments to expand accessibility across more regions. Our nationwide rollout across hospitals and clinics is underway, ensuring more people can benefit from early cardiovascular risk detection.
On World Heart Day, September 29, 2025, we will introduce new initiatives aimed at making preventive cardiology more accessible to everyone in India. Stay tuned for more updates."
With real-world validation and overwhelming demand from medical professionals, AnginaX AI is now officially open for hospitals and clinics across India. Over the next two months, our focus will be on expanding adoption, ensuring that doctors, hospitals, and clinics are equipped with a system that enhances their expertise while improving efficiency.
Get a 30-day Trial Opens
How to Register: htttps://anginax.ai
Medical professional Inquiries: operations@anginax.ai
